These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

314 related items for PubMed ID: 23008501

  • 1. Preclinical characterization of a novel class of 18F-labeled PET tracers for amyloid-β.
    Brockschnieder D, Schmitt-Willich H, Heinrich T, Varrone A, Gulyás B, Toth M, Andersson J, Boemer U, Krause S, Friebe M, Dinkelborg L, Halldin C, Dyrks T.
    J Nucl Med; 2012 Nov; 53(11):1794-801. PubMed ID: 23008501
    [Abstract] [Full Text] [Related]

  • 2. Characterization of AZD4694, a novel fluorinated Abeta plaque neuroimaging PET radioligand.
    Juréus A, Swahn BM, Sandell J, Jeppsson F, Johnson AE, Johnström P, Neelissen JA, Sunnemark D, Farde L, Svensson SP.
    J Neurochem; 2010 Aug; 114(3):784-94. PubMed ID: 20477945
    [Abstract] [Full Text] [Related]

  • 3. Synthesis and evaluation of two 18F-labeled 6-iodo-2-(4'-N,N-dimethylamino)phenylimidazo[1,2-a]pyridine derivatives as prospective radioligands for beta-amyloid in Alzheimer's disease.
    Cai L, Chin FT, Pike VW, Toyama H, Liow JS, Zoghbi SS, Modell K, Briard E, Shetty HU, Sinclair K, Donohue S, Tipre D, Kung MP, Dagostin C, Widdowson DA, Green M, Gao W, Herman MM, Ichise M, Innis RB.
    J Med Chem; 2004 Apr 22; 47(9):2208-18. PubMed ID: 15084119
    [Abstract] [Full Text] [Related]

  • 4. Preclinical and clinical study on [18F]DRKXH1: a novel β-amyloid PET tracer for Alzheimer's disease.
    Xu M, Guo J, Gu J, Zhang L, Liu Z, Ding L, Fu H, Ma Y, Liang S, Wang H.
    Eur J Nucl Med Mol Imaging; 2022 Jan 22; 49(2):652-663. PubMed ID: 34292345
    [Abstract] [Full Text] [Related]

  • 5. In vivo SPECT imaging of amyloid-β deposition with radioiodinated imidazo[1,2-a]pyridine derivative DRM106 in a mouse model of Alzheimer's disease.
    Chen CJ, Bando K, Ashino H, Taguchi K, Shiraishi H, Shima K, Fujimoto O, Kitamura C, Matsushima S, Uchida K, Nakahara Y, Kasahara H, Minamizawa T, Jiang C, Zhang MR, Ono M, Tokunaga M, Suhara T, Higuchi M, Yamada K, Ji B.
    J Nucl Med; 2015 Jan 22; 56(1):120-6. PubMed ID: 25476539
    [Abstract] [Full Text] [Related]

  • 6. 18F-labeled styrylpyridines as PET agents for amyloid plaque imaging.
    Zhang W, Kung MP, Oya S, Hou C, Kung HF.
    Nucl Med Biol; 2007 Jan 22; 34(1):89-97. PubMed ID: 17210465
    [Abstract] [Full Text] [Related]

  • 7. Synthesis and evaluation of novel ¹⁸F labeled 2-pyridinylbenzoxazole and 2-pyridinylbenzothiazole derivatives as ligands for positron emission tomography (PET) imaging of β-amyloid plaques.
    Cui M, Wang X, Yu P, Zhang J, Li Z, Zhang X, Yang Y, Ono M, Jia H, Saji H, Liu B.
    J Med Chem; 2012 Nov 08; 55(21):9283-96. PubMed ID: 22974116
    [Abstract] [Full Text] [Related]

  • 8. A dual fluorinated and iodinated radiotracer for PET and SPECT imaging of β-amyloid plaques in the brain.
    Watanabe H, Ono M, Kimura H, Kagawa S, Nishii R, Fuchigami T, Haratake M, Nakayama M, Saji H.
    Bioorg Med Chem Lett; 2011 Nov 01; 21(21):6519-22. PubMed ID: 21920750
    [Abstract] [Full Text] [Related]

  • 9. Synthesis and evaluation of 11C-labeled imidazo[2,1-b]benzothiazoles (IBTs) as PET tracers for imaging β-amyloid plaques in Alzheimer's disease.
    Yousefi BH, Manook A, Drzezga A, von Reutern B, Schwaiger M, Wester HJ, Henriksen G.
    J Med Chem; 2011 Feb 24; 54(4):949-56. PubMed ID: 21275403
    [Abstract] [Full Text] [Related]

  • 10. Preclinical Evaluation of 18F-JNJ64349311, a Novel PET Tracer for Tau Imaging.
    Declercq L, Rombouts F, Koole M, Fierens K, Mariën J, Langlois X, Andrés JI, Schmidt M, Macdonald G, Moechars D, Vanduffel W, Tousseyn T, Vandenberghe R, Van Laere K, Verbruggen A, Bormans G.
    J Nucl Med; 2017 Jun 24; 58(6):975-981. PubMed ID: 28232614
    [Abstract] [Full Text] [Related]

  • 11. PET imaging of brain with the beta-amyloid probe, [11C]6-OH-BTA-1, in a transgenic mouse model of Alzheimer's disease.
    Toyama H, Ye D, Ichise M, Liow JS, Cai L, Jacobowitz D, Musachio JL, Hong J, Crescenzo M, Tipre D, Lu JQ, Zoghbi S, Vines DC, Seidel J, Katada K, Green MV, Pike VW, Cohen RM, Innis RB.
    Eur J Nucl Med Mol Imaging; 2005 May 24; 32(5):593-600. PubMed ID: 15791432
    [Abstract] [Full Text] [Related]

  • 12. Preliminary Characterization and In Vivo Studies of Structurally Identical (18)F- and (125)I-Labeled Benzyloxybenzenes for PET/SPECT Imaging of β-Amyloid Plaques.
    Yang Y, Zhang X, Cui M, Zhang J, Guo Z, Li Y, Zhang X, Dai J, Liu B.
    Sci Rep; 2015 Jul 14; 5():12084. PubMed ID: 26170205
    [Abstract] [Full Text] [Related]

  • 13. Novel ¹⁸F-labeled benzoxazole derivatives as potential positron emission tomography probes for imaging of cerebral β-amyloid plaques in Alzheimer's disease.
    Cui M, Ono M, Kimura H, Ueda M, Nakamoto Y, Togashi K, Okamoto Y, Ihara M, Takahashi R, Liu B, Saji H.
    J Med Chem; 2012 Nov 08; 55(21):9136-45. PubMed ID: 22690944
    [Abstract] [Full Text] [Related]

  • 14. Preclinical Evaluation of 18F-RO6958948, 11C-RO6931643, and 11C-RO6924963 as Novel PET Radiotracers for Imaging Tau Aggregates in Alzheimer Disease.
    Honer M, Gobbi L, Knust H, Kuwabara H, Muri D, Koerner M, Valentine H, Dannals RF, Wong DF, Borroni E.
    J Nucl Med; 2018 Apr 08; 59(4):675-681. PubMed ID: 28970331
    [Abstract] [Full Text] [Related]

  • 15. [18F]Fluoroazabenzoxazoles as potential amyloid plaque PET tracers: synthesis and in vivo evaluation in rhesus monkey.
    Hostetler ED, Sanabria-Bohórquez S, Fan H, Zeng Z, Gammage L, Miller P, O'Malley S, Connolly B, Mulhearn J, Harrison ST, Wolkenberg SE, Barrow JC, Williams DL, Hargreaves RJ, Sur C, Cook JJ.
    Nucl Med Biol; 2011 Nov 08; 38(8):1193-203. PubMed ID: 21741254
    [Abstract] [Full Text] [Related]

  • 16. Preclinical properties of 18F-AV-45: a PET agent for Abeta plaques in the brain.
    Choi SR, Golding G, Zhuang Z, Zhang W, Lim N, Hefti F, Benedum TE, Kilbourn MR, Skovronsky D, Kung HF.
    J Nucl Med; 2009 Nov 08; 50(11):1887-94. PubMed ID: 19837759
    [Abstract] [Full Text] [Related]

  • 17. [(18)F]T807, a novel tau positron emission tomography imaging agent for Alzheimer's disease.
    Xia CF, Arteaga J, Chen G, Gangadharmath U, Gomez LF, Kasi D, Lam C, Liang Q, Liu C, Mocharla VP, Mu F, Sinha A, Su H, Szardenings AK, Walsh JC, Wang E, Yu C, Zhang W, Zhao T, Kolb HC.
    Alzheimers Dement; 2013 Nov 08; 9(6):666-76. PubMed ID: 23411393
    [Abstract] [Full Text] [Related]

  • 18. Synthesis and biological evaluation of 18F-labled 2-phenylindole derivatives as PET imaging probes for β-amyloid plaques.
    Fu H, Yu L, Cui M, Zhang J, Zhang X, Li Z, Wang X, Jia J, Yang Y, Yu P, Jia H, Liu B.
    Bioorg Med Chem; 2013 Jul 01; 21(13):3708-14. PubMed ID: 23673220
    [Abstract] [Full Text] [Related]

  • 19. Discovery and preclinical characterization of [18F]PI-2620, a next-generation tau PET tracer for the assessment of tau pathology in Alzheimer's disease and other tauopathies.
    Kroth H, Oden F, Molette J, Schieferstein H, Capotosti F, Mueller A, Berndt M, Schmitt-Willich H, Darmency V, Gabellieri E, Boudou C, Juergens T, Varisco Y, Vokali E, Hickman DT, Tamagnan G, Pfeifer A, Dinkelborg L, Muhs A, Stephens A.
    Eur J Nucl Med Mol Imaging; 2019 Sep 01; 46(10):2178-2189. PubMed ID: 31264169
    [Abstract] [Full Text] [Related]

  • 20. Characterization and first human investigation of FIBT, a novel fluorinated Aβ plaque neuroimaging PET radioligand.
    Yousefi BH, Manook A, Grimmer T, Arzberger T, von Reutern B, Henriksen G, Drzezga A, Förster S, Schwaiger M, Wester HJ.
    ACS Chem Neurosci; 2015 Mar 18; 6(3):428-37. PubMed ID: 25482310
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.